Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection

Future II Study Group - The Journal of infectious diseases, 2007 - academic.oup.com
Abstract Background. A quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV)
L1 virus-like-particle (VLP) vaccine has been shown to be 95%–100% effective in …
被引用次数：255 相关文章

[引用][C] Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection

LL Villa, G Perez, SK Kjær… - Journal of …, 2007 - researchportal.helsinki.fi
Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with
virological evidence of HPV infection — University of Helsinki Skip to main navigation Skip to …

Prophylactic Efficacy of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Women with Virological Evidence of HPV Infection

FUTURE II Study Group - The Journal of Infectious Diseases, 2007 - JSTOR
Background. A quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV) L1 virus-
like-particle (VLP) vaccine has been shown to be 95%-100% effective in preventing cervical …

Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection

LL Villa, G Perez, SK Kjaer, J Paavonen… - Journal of Infectious …, 2007 - portal.research.lu.se
Background. A quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV) L1 virus-
like-particle (VLP) vaccine has been shown to be 95%-100% effective in preventing cervical …

[引用][C] Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. Commentaries

A HILDESHEIM, R HERRERO - The Journal of infectious …, 2007 - pascal-francis.inist.fr
Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with
virological evidence of HPV infection. Commentaries CNRS Inist Pascal-Francis CNRS …

Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV Infection

LL Villa, G Perez, SK Kjær… - Journal of …, 2007 - augusta.elsevierpure.com
Background. A quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV) L1 virus-
like-particle (VLP) vaccine has been shown to be 95%-100% effective in preventing cervical …

Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection.

The Journal of Infectious Diseases, 2007 - europepmc.org
Background A quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV) L1 virus-
like-particle (VLP) vaccine has been shown to be 95%-100% effective in preventing cervical …

Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection

FUTURE II Study Group - 2007 - pubmed.ncbi.nlm.nih.gov
Background A quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV) L1 virus-
like-particle (VLP) vaccine has been shown to be 95%-100% effective in preventing cervical …

Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection

LL Villa, G Perez, SK Kjaer, J Paavonen… - Journal of Infectious …, 2007 - lup.lub.lu.se
Background. A quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV) L1 virus-
like-particle (VLP) vaccine has been shown to be 95%-100% effective in preventing cervical …

Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV Infection

LL Villa, G Perez, SK Kjær… - Journal of Infectious …, 2007 - pure.johnshopkins.edu
Background. A quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV) L1 virus-
like-particle (VLP) vaccine has been shown to be 95%-100% effective in preventing cervical …